PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New strategy to attack tumor-feeding blood vessels

New strategy to attack tumor-feeding blood vessels
2011-06-07
(Press-News.org) Scientists at the Walter and Eliza Hall Institute have discovered a key molecule needed to kill the blood vessels that supply tumours.

The research team from the institute's Molecular Genetics of Cancer and Cancer and Haematology divisions found that for anti-cancer therapies that target tumour blood vessels to work the death- inducing molecule Bim is required. The finding could lead to improved anti-cancer treatments that are based on a two- or three-pronged attack on both the tumour and its blood supply. The research will be published online in the Journal of Experimental Medicine today.

The growth of solid tumours, such as lung cancer, breast cancer and melanoma, depends on nutrients and oxygen being provided by the tumour blood supply. Cancer cells encourage the growth of blood vessels to feed a tumour by producing the hormone-like protein, vascular endothelial growth factor (VEGF). The research by Drs Edwina Naik, Leigh Coultas and Lorraine O'Reilly, and Professors Jerry Adams and Andreas Strasser showed that VEGF produced by tumours blocks production of Bim in the cells that line the tumour blood vessels.

New 'anti-angiogenic' medications that attack the blood vessels within tumours are showing promise in starving many types of cancers by reducing their blood supply.

In this study, in experimental melanoma, lung cancer and breast cancer models, Bim levels increased in the cells lining the blood vessels when VEGF was depleted by anti-angiogenic drugs, ultimately killing the blood vessel cells. VEGF depletion reduced the number of blood vessels in tumours, making the tumours shrink. However, in mice in which the blood vessels do not express Bim, VEGF depletion did not affect the number of tumour-associated blood vessels, and tumours grown in Bim-deficient mice did not respond to anti-angiogenic treatments.

Dr Strasser said this finding suggests that strategies for treating tumours by attacking the tumour blood supply could be optimised by incorporating drugs called BH3-mimetics that cause cell death by acting like Bim at a molecular level. "Similarly, therapies that increase the amount of Bim in tumour blood vessels could enhance the effects of anti-angiogenic agents," Dr Strasser said.

"BH3 mimetics may have two beneficial effects in cancer therapy. Our previous research had showed they can directly trigger death in tumour cells, particularly when the tumour is also attacked by chemotherapeutic drugs. We now think BH3-mimetics could also impact tumour cells indirectly by killing endothelial cells within tumours.

"This suggests that a promising new approach to the therapy of solid tumours may be to use a three-medication combination of a drug that specifically targets the tumour cell, an anti- angiogenic agent to impair the tumour blood vessels, plus a BH3 mimetic that will help the anti- tumour drug to directly kill the tumour cells and also will help the anti-angiogenic agent to kill the intra-tumoral endothelial cells, which in turn will starve the tumour, causing even more tumour cell death."



INFORMATION:

The research was supported by the Cancer Council Victoria, the National Health and Medical Research Council, the Australian Research Council, the US National Institutes of Health, the Leukemia and Lymphoma Society and Genentech.

[Attachments] See images for this press release:
New strategy to attack tumor-feeding blood vessels

ELSE PRESS RELEASES FROM THIS DATE:

Singapore researchers invent broadband graphene polarizer

2011-06-07
Researchers at the National University of Singapore have invented a graphene-based polarizer that can broaden the bandwidth of prevailing optical fibre-based telecommunication systems. The graphene research team, led by Professor Kian Ping Loh at the National University of Singapore, invented an ultra-slim broadband polarizer that uses graphene, a single-atomic-layer crystallized carbon, to convert light beam into polarized light. This is the first experimental demonstration of using graphene as an ultrathin waveguide to couple and modulate light. Light modulation by ...

Research creates nanoparticles perfectly formed to tackle cancer

2011-06-07
Researchers from the University of Hull have discovered a way to load up nanoparticles with large numbers of light-sensitive molecules to create a more effective form of photodynamic therapy (PDT) for treating cancer. Photodynamic therapy uses molecules which, when irradiated with light, cause irreparable damage to cells by creating toxic forms of oxygen, called reactive oxygen species. Most PDT works with individual light-sensitive molecules – but the new nanoparticles could each carry hundreds of molecules to a cancer site. A number of different light-sensitive molecules ...

Molecular movements could lead to new way to treat cancer

2011-06-07
Work by researchers at Queen Mary, University of London could point to a new way to treat aggressive types of cancer. The scientists have found that a molecule called Met is responsible for stimulating the growth and spread of cancer because it is relocating to the wrong part of the cell. Experiments in the lab suggest that moving Met molecules from the inside of the cell to the cell surface could halt the growth of cancer cells and even cause tumours to shrink. Met molecules are involved in the growth of cells in the human body but they are usually only active in ...

Methane gas from cows -- the proof is in the poo

2011-06-07
Scientists could have a revolutionary new way of measuring how much of the potent greenhouse gas methane is produced by cows and other ruminants, thanks to a surprising discovery in their poo. Researchers from the University of Bristol and the Teagasc Animal and Grassland Research Centre in Ireland, have found a link between methane production and levels of a compound called archaeol in the faeces of several fore-gut fermenting animals including cows, sheep and deer. The compound could potentially be developed as a biomarker to estimate the methane production from ...

Kinder, gentler video games may actually be good for players

2011-06-07
COLUMBUS, Ohio – While violent video games may lead to more aggression and anger in players, a new study shows that the opposite is also true: relaxing video games can make people happier and more kind. "With all the evidence about the dangers of violent video games, it's good to know that game players can choose games that will provide a positive experience," said Brad Bushman, co-author of the study and professor of communication and psychology at Ohio State University. Bushman has conducted many studies showing the bad effects of violent games, especially on teens ...

Weizmann Institute Observatory captures images of a new supernova

2011-06-07
Exploding stars are the 'factories' that produce all the heavy elements found, among other places, in our bodies. In this sense, we are all stardust. These exploding stars – supernovae – are highly energetic events that can occasionally light up the night sky. Such an explosion generally involves disruption in the balance between gravity – which pulls the star's material inward – and the thermonuclear reaction at the star's core – which heats it and pushes it outward. Certain types of stars that go in this way have a much bigger mass (10-100 times) and are much younger ...

Bakon Vodka Signs with Southern Wine & Spirits and Expands Relationship with Republic National As Sales Approach One Million Dollars

Bakon Vodka Signs with Southern Wine & Spirits and Expands Relationship with Republic National As Sales Approach One Million Dollars
2011-06-07
The world's first 'meat-flavored spirit', Bakon Vodka (www.bakonvodka.com), today announced a new partnership with the number one distributor in the United States, Southern Wine & Spirits. Bakon Vodka has also strategically expanded its partnerships with Republic National Distributing Company and California's BevMo! stores to increase product accessibility as a result of growing demand for the bacon vodka infusion. Currently available in 32 states, the acclaimed and award-winning spirit is expected to be available in all 50 states and break sales of one million dollars ...

Surgically shrinking the stomach when conservative weight-loss treatments fail

2011-06-07
The treatment of obesity still needs improvement. In the current issue of Deutsches Ärzteblatt International, Norbert Runkel and colleagues present a new, interdisciplinary S3 guideline entitled "Bariatric Surgery" (Dtsch Arztebl Int 2011; 108[20]: 341𔃄). One in two persons in Germany is overweight, and every fifth one is obese. Conservative treatment is considered to have been exhausted when it fails to bring about a 10% to 20% loss of weight in one year in a patient whose initial body-mass index was between 35 and 40 kg/m2. In this situation, bariatric surgery ...

Hard or soft: At the touch of a button

2011-06-07
This world-first has its origins in Hamburg. Jörg Weißmüller, a materials scientist at both the Technical University of Hamburg and the Helmholtz Center Geesthacht, has carried out research on this groundbreaking development, working in cooperation with colleagues from the Institute for Metal Research in Shenyang, China. The 51-year-old researcher from the Saarland referred to his fundamental research, which opens the door to a multitude of diverse applications, as "a breakthrough in the material sciences". The new metallic high-performance material is described by Prof. ...

Survival niche for cancer cells

2011-06-07
Cancer cells do not grow equally well everywhere in the body. Often, they first create the conditions in which they can grow. Many years ago researchers discovered that solid tumors attract blood vessels to ensure their supply of nutrients by secreting specific factors. Now the immunologist Dr. Uta Höpken (Tumor and Immunogenetics Research Group at the Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch in the Helmholtz Association) and the hematologist Dr. Armin Rehm (Charité – Virchow-Klinikum, Department of Hematology, Oncology and Tumor Immunology, MDC) have ...

LAST 30 PRESS RELEASES:

New way to find “aged” cells marks fresh approach for research into ageing

From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency

Variability in heart rate during sleep may reveal early signs of stroke, depression or cognitive dysfunction, new study shows

New method to study catalysts could lead to better batteries

Current Molecular Pharmacology impact factor rises to 2.9, achieving Q2 ranking in the Pharmacology & Pharmacy category in 2024 JCR

More time with loved ones for cancer patients spared radiation treatment

New methods speed diagnosis of rare genetic disease

Genetics of cardiomyopathy risk in cancer survivors differ by age of onset

Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism

Targeting fusion protein’s role in childhood leukemia produces striking results

Clear understanding of social connections propels strivers up the social ladder

New research reveals why acute and chronic pain are so different – and what might make pain last

Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming

New research casts doubt on ancient drying of northern Africa’s climate

Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns

AI development: seeking consistency in logical structures

Want better sleep for your tween? Start with their screens

Cancer burden in neighborhoods with greater racial diversity and environmental burden

Alzheimer disease in breast cancer survivors

New method revolutionizes beta-blocker production process

Mechanism behind life-threatening cancer drug side-effect revealed

Weighted vests might help older adults meet weight loss goals, but solution for corresponding bone loss still elusive

Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments

Breast cancer patients’ microbiome may hold key to avoiding damaging heart side-effects of cancer therapies

Exercise-induced protein revives aging muscles and bones

American College of Cardiology issues guidance on weight management drugs

Understanding the effect of bedding on thermal insulation during sleep

Cosmic signal from the very early universe will help astronomers detect the first stars

With AI, researchers find increasing immune evasion in H5N1

Study finds hidden effects of wildfires on water systems

[Press-News.org] New strategy to attack tumor-feeding blood vessels